IL-10家族在肠纤维化中作用的研究进展

doi:10.13481/j.1671-587x.20170436

[1] Shelley-Fraser G, Borley NR, Warren BF, et al. The connective tissue changes of Crohn's disease[J]. Histopathology, 2012,60(7):1034-1044.
[2] Fiocchi C, Lund PK. Themes in fibrosis and gastrointestinal inflammation[J]. Am J Physiol Gastrointest Liver Physiol, 2011,300(5):G677-G683.
[3] Sziksz E, Pap D, Lippai R, et al. Fibrosis related inflammatory mediators:role of the IL-10 cytokine family[J]. Mediators Inflamm, 2015, 2015:764641.
[4] Hazlett LD, Jiang X, McClellan SA. IL-10 function, regulation, and in bacterial keratitis[J]. J Ocul Pharmacol Ther, 2014,30(5):373-380.
[5] Pestka S, Krause CD, Sarkar D, et al. Interleukin-10 and related cytokines and receptors[J]. Annu Rev Immunol, 2004, 22:929-979.
[6] Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes[J]. J Interferon Cytokine Res, 1999,19(6):563-573.
[7] Mrowietz U, Seifert O. Keloid scarring:new treatments ahead[J]. Actas Dermosifiliogr, 2009, 100(Suppl 2):75-83.
[8] Kabel AM, Abd Elmaaboud MA, Atef A, et al. Ameliorative potential of linagliptin and/or calcipotriol on bleomycin-induced lung fibrosis:In vivo and in vitro study[J]. Environ Toxicol Pharmacol, 2017,50:216-226.
[9] Barbarin V, Petrek M, Kolek V, et al. Characterization of p40 and IL-10 in the BALF of patients with pulmonary sarcoidosis[J]. J Interferon Cytokine Res, 2003,23(8):449-456.
[10] Kucejko W, Chyczewska E, Naumnik W, et al. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis[J]. Folia Histochem Cytobiol, 2009,47(2):225-230.
[11] Abdalla AE, Lambert N, Duan X, et al. Interleukin-10 Family and Tuberculosis:An Old Story Renewed[J]. Int J Biol Sci, 2016,12(6):710-717.
[12] Jennings P, Crean D, Aschauer L, et al. Interleukin-19 as a translational indicator of renal injury[J]. Arch Toxicol, 2015,89(1):101-106.
[13] Xie J, Li X, Meng D, et al. Transduction of interleukin-10 through renal artery attenuates vascular neointimal proliferation and infiltration of immune cells in rat renal allograft[J]. Immunol Lett, 2016,176:105-113.
[14] Jin Y, Liu R, Xie J, et al. Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model[J]. Lab Invest, 2013,93(7):801-811.
[15] Chen WC, Lee BG, Park DW, et al. Controlled dual delivery of fibroblast growth factor-2 and interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair[J]. Biomaterials, 2015,72:138-151.
[16] Kondo H, Takahashi N, Gotoh K, et al. Splenectomy exacerbates atrial inflammatory fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats:Possible role of spleen-derived interleukin-10[J]. Heart Rhythm, 2016,13(1):241-250.
[17] Nobili V, Alkhouri N, Alisi A, et al. Nonalcoholic fatty liver disease:a challenge for pediatricians[J]. JAMA Pediatr, 2015,169(2):170-176.
[18] Khawar MB, Azam F, Sheikh N, et al. How does interleukin-22 mediate liver regeneration and prevent injury and fibrosis?[J]. J Immunol Res, 2016, 2016:2148129.
[19] Hung KS, Lee TH, Chou WY, et al. Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice[J]. Biochem Biophys Res Commun, 2005,336(1):324-331.
[20] Fonseca-Camarillo G, Furuzawa-Carballeda J, Lorente L, et al. IL-10 and IL-20 expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis[J]. J Clin Immunol, 2013,33(3):640-648.
[21] Santaolalla R, Mañé J, Pedrosa E, et al. Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease[J]. Inflamm Bowel Dis, 2011,17(7):1490-1500.
[22] Guo X,Li MG,Li SS,et al. Tumor necrosis factor suppresses interleukin-10 in peripheral B cells via upregulating Bcl2-like protein 12 in patients with inflammatory bowel disease[J].Cell Biochem Funct,2017,35(2):77-82.
[23] Correa I, Veny M, Esteller M, et al. Defective IL-10 production in severe phenotypes of Crohn's disease[J]. J Leukoc Biol, 2009,85(5):896-903.
[24] Matsuo Y, Azuma YT, Kuwamura M, et al. Interleukin 19 reduces inflammation in chemically induced experimental colitis[J]. Int Immunopharmacol, 2015,29(2):468-475.
[25] Azuma YT, Matsuo Y, Kuwamura M, et al. Interleukin-19 protects mice from innate-mediated colonic inflammation[J]. Inflamm Bowel Dis, 2010,16(6):1017-1028.
[26] Yamamoto-Furusho JK, Alvarez-León E, Fragoso JM, et al. Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis[J]. Hum Immunol, 2011,72(11):1029-1032.
[27] Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines——from host defence to tissue homeostasis[J]. Nat Rev Immunol, 2014,14(12):783-795.
[28] Elson CO, Cong Y, Weaver CT, et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice[J]. Gastroenterology, 2007,132(7):2359-2370.
[29] Pickert G, Neufert C, Leppkes M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing[J]. J Exp Med, 2009,206(7):1465-1472.
[30] Yu LZ, Wang HY, Yang SP, et al. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis[J]. World J Gastroenterol, 2013,19(17):2638-2649.
[31] Fonseca-Camarillo G, Furuzawa-Carballeda J, Granados J, et al. Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients:a cross-sectional study[J]. Clin Exp Immunol, 2014,177(1):64-75.
[32] Troncone E, Marafini I, Pallone F, et al. Th17 cytokines in inflammatory bowel diseases:discerning the good from the bad[J]. Int Rev Immunol, 2013,32(5/6):526-533.
[33] Balaji S,Wang X,King A,et al.Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling[J].FASEB J, 2017, 31(3):868-881.
[34] Li MC, He SH. IL-10 and its related cytokines for treatment of inflammatory bowel disease[J]. World J Gastroenterol, 2004,10(5):620-625.
[35] Marlow GJ, van Gent D, Ferguson LR. Why interleukin-10 supplementation does not work in Crohn's disease patients[J]. World J Gastroenterol, 2013,19(25):3931-3941.

Research progress in role of IL-10 cytokine family in intestinal fibrosis

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 12

Metrics

Comments

Recommended 0

[1]	LI Jia, YANG Luoluo, ZHOU Changli, HE Ping, SUN Xun, MENG Xiangwei. Analysis on risk factors related to incidence of patientswithcolorectal polyps [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 646-650.
[2]	LIU Yang, LIU Zhi, LI Fenge, KONG Fanli. Therapeutic effect of mosapride citrate on gastrointestinal tract function disorder of patients with Parkinson's syndrome [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 125-129.
[3]	LI Hui,ZHAO Li-jing,DU Yu,YANG Tie-zheng,LI Guo-feng,CHEN Liang,ZHI Chen-yang,LI Na,ZHOU Jian-hua. Therapeutic effect of suppository of Jiechang An combined with  Shuxue Ning on rats with ulcerative colitis and their mechanisms [J]. Journal of Jilin University Medicine Edition, 2013, 39(3): 488-493.
[4]	WANG Min, JI Fu-jian, JIN Hong-yong,CHEN Xue-bo, YU Jie, FANG Xue-dong. Analysis of clinico-pathologic features on \|metastasis of \|lymph nodes around rectum in patients with rectal carcinoma [J]. J4, 2011, 37(2): 345-350.
[5]	WANG Zhe, JIANG Yi-Zhong, SONG Yang, ZHOU Chang-Yu. Changes of clotting function indexes in elder patients with ulcerative colitis and significances [J]. J4, 2009, 35(3): 553-555.
[6]	CHEN Xi，YANG Shi-zhong，CHI Bao-rong. Reproduction of rat inflammatory bowel disease model and intervention effect of Changkangyin on it [J]. J4, 2008, 34(2): 262-265.
[7]	YU Jin-hai,SOU Jian,LI You-zhu,WANG Zhong-yi,LIU Guo-hui,WANG Quan. Inhibitory effect of Fe³⁺-CMC on expressions of TGF-β and FGF  [J]. J4, 2007, 33(6): 1026-1028.
[8]	. Clinical application of nutrision in intestinal preparing before colonoscopy [J]. J4, 2005, 31(1): 142-143.
[9]	. Clinical significances of mean platelet volume and D-dipolymerin patients with inflammatory bowel disease [J]. J4, 2004, 30(6): 947-948.
[10]	. Clinical curative effects of ChangYanKang oral liquid for ulcerative colitis [J]. J4, 2004, 30(5): 785-786.
[11]	LI Tiantian, YANG Lanlan, JIA Shengnan, JIN Zhenjing. A case report of diagnosis and treatment of abdominal cocoon and literature review [J]. Journal of Jilin University Medicine Edition, 2015, 41(01): 172-174.
[12]	WANG Liying, YANG Yong, LI Zhandong, LI Dongfu, LIU Libin, WANG Min. Therapentic effect of siRNA inhibiting CD40 expression in dendritic cells on inflammatory bowel disease in rats [J]. Journal of Jilin University Medicine Edition, 2015, 41(01): 54-59.